Abstract
Hepatocellular carcinoma (HCC) has a recurrence rate of up to 70% in 5 years after resection, detrimentally lowering survival. The role of adjuvant therapy remains controversial; therefore, the aim of this study was to evaluate the disease-free and overall survival of patients with HCC, not candidates for transplantation, undergoing resection and adjuvant hepatic artery infusion therapy vs resection alone. Our meta-analysis showed that adjuvant HAIC improves overall and disease-free survival after resection, especially in tumors ≥7 cm.
Original language | English (US) |
---|---|
Pages (from-to) | 455-463 |
Number of pages | 9 |
Journal | Journal of Surgical Oncology |
Volume | 119 |
Issue number | 4 |
DOIs | |
State | Published - Mar 15 2019 |
Externally published | Yes |
Keywords
- adjuvant hepatic artery infusion therapy (HAIT)
- hepatocellular carcinoma (HCC)
- resection
ASJC Scopus subject areas
- Surgery
- Oncology